Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Anticancer Research
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Anticancer Research

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Visit us on Facebook
  • Follow us on Linkedin
Research ArticleClinical Studies

Phase I Study of Combination Therapy With Weekly Nanoparticle Albumin-bound Paclitaxel and Cyclophosphamide in Metastatic Breast Cancer Patients

DAISUKE OTA, SOTARO AKATSUKA, TSUNEHIRO NISHI, TAKAO KATO, MASASHI TAKEUCHI, MUNECHIKA TSUJI and ATSUSHI FUKUUCHI
Anticancer Research December 2019, 39 (12) 6903-6907; DOI: https://doi.org/10.21873/anticanres.13910
DAISUKE OTA
1Department of Breast and Endocrine Surgery, Mitsui Memorial Hospital, Tokyo, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: d-ota{at}mitsuihosp.or.jp
SOTARO AKATSUKA
2Department of Medical Oncology, Mitsui Memorial Hospital, Tokyo, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
TSUNEHIRO NISHI
1Department of Breast and Endocrine Surgery, Mitsui Memorial Hospital, Tokyo, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
TAKAO KATO
1Department of Breast and Endocrine Surgery, Mitsui Memorial Hospital, Tokyo, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
MASASHI TAKEUCHI
1Department of Breast and Endocrine Surgery, Mitsui Memorial Hospital, Tokyo, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
MUNECHIKA TSUJI
1Department of Breast and Endocrine Surgery, Mitsui Memorial Hospital, Tokyo, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
ATSUSHI FUKUUCHI
1Department of Breast and Endocrine Surgery, Mitsui Memorial Hospital, Tokyo, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Article Information

vol. 39 no. 12 6903-6907
DOI 
https://doi.org/10.21873/anticanres.13910
PMID 
31810960

Published By 
International Institute of Anticancer Research
Print ISSN 
0250-7005
Online ISSN 
1791-7530
History 
  • Received September 25, 2019
  • Revision received November 8, 2019
  • Accepted November 11, 2019
  • Published online December 6, 2019.

Copyright & Usage 
Copyright© 2019, International Institute of Anticancer Research (Dr. George J. Delinasios), All rights reserved

Author Information

  1. DAISUKE OTA1⇑,
  2. SOTARO AKATSUKA2,
  3. TSUNEHIRO NISHI1,
  4. TAKAO KATO1,
  5. MASASHI TAKEUCHI1,
  6. MUNECHIKA TSUJI1 and
  7. ATSUSHI FUKUUCHI1
  1. 1Department of Breast and Endocrine Surgery, Mitsui Memorial Hospital, Tokyo, Japan
  2. 2Department of Medical Oncology, Mitsui Memorial Hospital, Tokyo, Japan
  1. Correspondence to: Daisuke Ota, MD, Ph.D., Department of Breast and Endocrine Surgery, Mitsui Memorial Hospital, Kanda-Izumicho 1, Chiyoda-ku, Tokyo 101- 8643, Japan. Tel: +81 338629111, Fax: +81 338625100, e-mail: d-ota{at}mitsuihosp.or.jp
View Full Text

Statistics from Altmetric.com

Cited By...

  • Citations
  • Google Scholar

This article has not yet been cited by articles in journals that are participating in Crossref Cited-by Linking.

PreviousNext
Back to top

In this issue

Anticancer Research
Vol. 39, Issue 12
December 2019
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Back Matter (PDF)
  • Ed Board (PDF)
  • Front Matter (PDF)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Anticancer Research.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Phase I Study of Combination Therapy With Weekly Nanoparticle Albumin-bound Paclitaxel and Cyclophosphamide in Metastatic Breast Cancer Patients
(Your Name) has sent you a message from Anticancer Research
(Your Name) thought you would like to see the Anticancer Research web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
3 + 8 =
Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.
Citation Tools
Phase I Study of Combination Therapy With Weekly Nanoparticle Albumin-bound Paclitaxel and Cyclophosphamide in Metastatic Breast Cancer Patients
DAISUKE OTA, SOTARO AKATSUKA, TSUNEHIRO NISHI, TAKAO KATO, MASASHI TAKEUCHI, MUNECHIKA TSUJI, ATSUSHI FUKUUCHI
Anticancer Research Dec 2019, 39 (12) 6903-6907; DOI: 10.21873/anticanres.13910

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Reprints and Permissions
Share
Phase I Study of Combination Therapy With Weekly Nanoparticle Albumin-bound Paclitaxel and Cyclophosphamide in Metastatic Breast Cancer Patients
DAISUKE OTA, SOTARO AKATSUKA, TSUNEHIRO NISHI, TAKAO KATO, MASASHI TAKEUCHI, MUNECHIKA TSUJI, ATSUSHI FUKUUCHI
Anticancer Research Dec 2019, 39 (12) 6903-6907; DOI: 10.21873/anticanres.13910
Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Patients and Methods
    • Results
    • Discussion
    • Acknowledgements
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • PDF

Related Articles

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • Optimizing Biopsy Decisions in PI-RADS 3-4 Lesions: Integrating PSA-derived Biomarkers to Reduce Unnecessary Procedures
  • Surgical Outcomes and Postoperative Changes in Nutritional Indexes and Sarcopenia Markers in Oldest-old Patients With Resected Biliary Tract Cancer: A Retrospective Cohort Study
  • Effect of Tissue Sample Type on The Evaluation of PD-L1 (SP142) Expression in Breast Cancer
Show more Clinical Studies

Keywords

  • nab-paclitaxel
  • cyclophosphamide
  • Metastatic breast cancer
Anticancer Research

© 2026 Anticancer Research

Powered by HighWire